Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
17.99 USD | +0.11% | -5.71% | -21.88% |
10/05 | UBS Adjusts Privia Health Group Price Target to $26.50 From $29, Maintains Buy Rating | MT |
09/05 | Transcript : Privia Health Group, Inc., Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-21.88% | 214.65Cr | |
+17.18% | 8.31TCr | |
-28.48% | 7.09TCr | |
+4.93% | 2.83TCr | |
-7.44% | 1.77TCr | |
+1.75% | 1.74TCr | |
+2.10% | 1.56TCr | |
+7.02% | 1.35TCr | |
+64.96% | 1.27TCr | |
+7.43% | 1.28TCr |
- Stock Market
- Equities
- PRVA Stock
- News Privia Health Group, Inc.
- Privia Health Group's Q3 Adjusted Earnings, Revenue Rise; 2023 Revenue Outlook Updated